Device Trial Radar · NCT05662748
Comparison Between Manta and Prostar Closure Devices
Last checked: Nov 20, 2026Latest source record: Dec 22, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
250
Actual
Start
Jan 20, 2020
Primary completion
Mar 30, 2021
Study completion Mar 30, 2021
Sponsor
- Lead sponsor
- RWTH Aachen UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Dec 22, 2022
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Use of the closure device in patient with percutaneous transfemoral aortic valve replacement
Conditions
- Aortic Valve Stenosis
Interventions
Transfemoral aortic valve replacementDevice
aortic valve replacement
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety endpoints during index hospitalisationTime frame: 2018 - 2020
- Safety endpoints during index hospitalisation ( bleeding)Time frame: 2018-2020
- Safety endpoints during index hospitalisation ( death )Time frame: 2018-2020
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Universitätsklinikum Aachen
Aachen, North Rhine-Westphalia, Germany
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.